Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study. The new approach, which ...

Switching back from infliximab biosimilar SB2 to reference infliximab (Remicade) did not affect clinical disease activity or ...

Noninvasive monitoring methods, such as enterography and ultrasound, are becoming increasingly recognized as essential tools ...

Thetis Pharmaceuticals LLC (“Thetis”), a clinical-stage company developing TP-317, a first-in-class, small molecule drug ...

Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic ...

CJRB-201', a proprietary strain of Faecalibacterium with potent its anti-inflammatory effects, has demonstrated the strongest ...

Doctors may use blood, stool, and imaging tests to help diagnose IBD. However, endoscopy with biopsy is often essential to confirming a diagnosis and distinguishing between the two types.

Selectively binds and activates CD8 Treg; does not activate cells that express only one target, including other ICOS-expressing immune cells Extends survival and decreases disease score in a ...

IBD is the collective term for Crohn's disease and Ulcerative ... confident that its novel hAEC exosome platform is highly effective in pre-clinical models over a range of conditions including ...